Evicenter
Trodelvy (sacituzumab govitecan-hziy) in Metastatic triple-negative breast cancer
Manufacturer
Gilead Sciences, Inc.
Prescribing information
Trodelvy (opens in a new tab)
Questions
47
Last updated

All questions

Guidelines: Trodelvy (sacituzumab govitecan-hziy) in metastatic triple-negative breast cancer

1 question · 2 sources

Guidelines

Does NCCN recommend TRODELVY for metastatic TNBC?